Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim, Cellcentric, CNS, Entrada, Fluoguide, Index, Ingeneron, Innovent.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adlai Nortye Biopharma, Aribio, Brii Biosciences, Certa Therapeutics, Neuren Pharmaceuticals, SCG Cell Therapy, Visen Pharmaceuticals.